Aurobindo Pharma consolidated net profit declines 9.66% in the December 2024 quarter

Sales rise 8.55% to Rs 7893.15 crore

Net profit of Aurobindo Pharma declined 9.66% to Rs 845.81 crore in the quarter ended December 2024 as against Rs 936.29 crore during the previous quarter ended December 2023. Sales rose 8.55% to Rs 7893.15 crore in the quarter ended December 2024 as against Rs 7271.23 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales7893.157271.23 9 OPM %19.9921.99 -PBDT1618.381685.69 -4 PBT1199.851262.42 -5 NP845.81936.29 -10

Powered by Capital Market - Live News